Inherited thrombophilia is a significant pre-disposing factor for pregnancy-related disorders and recurrent miscarriage, warranting documentation for potential early treatment.
Answers are grounded in this paper and cite their sources.
Should not yet alter thrombophilia screening in pregnancy; leaves open whether documenting hemostasis variants improves outcomes.
The development of thrombotic disorders is a major threat for young women during pregnancy. It is one of the main causes of pregnancy-related disorders, which may also result in harm for the conceptus. Successful pregnancies require an even balance of coagulation and fibrinolysis, in order to secure stabilization of the basal plate as well as adequate placental perfusion. Thrombophilia is a laboratory definition for pre-disposing factors of thrombosis, which can be inherited or acquired. Many individuals, who carry a thrombotic defect remain asymptomatic, at least until additional boosting factors arise. The documentation of thrombophilic causes of recurrent miscarriage or pregnancy-related disorders is important, because of availability of effective early treatment. There is a rapidly growing awareness on the relationship of genetic factors influencing hemostasis and pregnancy-related disorders. The aim of our review is to summarize this knowledge, focusing on common genetic variations.
No takes yet. Share an insight, caveat, or question.
Buchholz et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: